BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Xencor Reports Fourth Quarter and Full Year 2022 Financial Results

  Xencor, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a review of recent business and clinical highlights.

  February 23, 2023

   · 

  14 min read
• Business

  Tonix Pharmaceuticals Announces New Board Member, R. Newcomb Stillwell

  Tonix Pharmaceuticals Holding Corp. today announced the appointment of R. Newcomb Stillwell to its Board of Directors, to be effective as of March 15, 2023.

  February 23, 2023

   · 

  5 min read
• Business

  Inogen Announces Fourth Quarter and Full Year 2022 Financial Results

  Inogen, Inc today announced financial results for the fourth quarter and the full year ended December 31, 2022.

  February 23, 2023

   · 

  17 min read
• Biotech Bay

  ABVC BioPharma Receives $3.175 Million Investment From The Lind Partners to Continue Clinical Trials

  ABVC BioPharma, Inc. today announced it has closed a funding agreement for gross proceeds of $3.175 million (the “Investment”) with Lind Global Fund II, LP, an investment fund managed by The Lind Partners (together “Investor” or “Lind”), a New York-based institutional fund manager.

  February 23, 2023

   · 

  5 min read
• Business

  Prothena Reports Fourth Quarter and Full Year 2022 Financial Results, and Provides Financial Guidance and Business Highlights

  Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the fourth quarter and full year 2022.

  February 23, 2023

   · 

  15 min read
• Business

  Universal Display Corporation Announces Fourth Quarter and Full Year 2022 Financial Results

  Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today reported financial results for the fourth quarter and full year ended December 31, 2022.

  February 23, 2023

   · 

  12 min read
• Biotech Beach

  Inogen to Provide Strategy Update on February 27, 2023

  Inogen, Inc. today announced that it will host a conference call on Monday, February 27, 2023, at 10:00 a.m. Eastern Time.

  February 23, 2023

   · 

  1 min read
• Business

  Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update

  Baudax Bio, Inc. today reported financial results for the fourth quarter and year ended December 31, 2022, updated the status of the neuromuscular blocking (NMB) agent development program, and provided an overview of other corporate and financial developments.

  February 23, 2023

   · 

  19 min read
• Business

  ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results

  ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three months and full year ended December 31, 2022.

  February 23, 2023

   · 

  15 min read
• BioMidwest

  Heska to Present at Three Upcoming Institutional Investor Conferences

  Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska’s management team will present at three institutional investor conferences in March 2023.

  February 23, 2023

   · 

  2 min read